Variables | POPF group (n = 54) | non-POPF group (n = 138) | P value |
---|---|---|---|
Age, year, median (range) | 69.7 (31–84) | 70.9 (17–86) | 0.604 |
Sex, male, (n, %) | 42 (77.8%) | 79 (57.2%) | 0.008 |
Body mass index, median (range) | 23.3 (16.5–29.6) | 21.5 (15.1–31.5) | 0.001 |
Histological diagnosis | Â | Â | 0.001 |
 pancreatic ductal adenocarcinoma | 9 (16.7%) | 64 (46.4%) |  |
 acinar sell cancer | 0 (0%) | 1 (0.7%) |  |
 bile duct cancer | 22 (40.7%) | 20 (14.5%) |  |
 carcinoma of the papilla of Vater | 12 (22.2%) | 21 (15.2%) |  |
 IPMN | 6 (11.1%) | 17 (12.3%) |  |
 PNET | 1 (1.9%) | 6 (4.3%) |  |
 SPN | 1 (1.9%) | 1 (0.7%) |  |
 Others | 3 (5.6%) | 8 (5.8%) |  |
Preoperative biliary drainage, present, (n, %) | 30 (55.6%) | 53 (38.4%) | 0.031 |
Pancreatic texture of remnant pancreas, soft, (n, %) | 49 (90.7%) | 68 (49.3%) | <  0.001 |
Diameter of main pancreatic duct, median (range), mm | 2.6 (1.0–8.9) | 4.3 (1.0–12.7) | <  0.001 |
Operative time, median (range), (min) | 545 (403–823) | 525 (309–780) | 0.271 |
Intraoperative blood loss, median (range), (ml) | 570 (64–4016) | 557 (95–2950) | 0.240 |
Method of pancreaticojejunostomy, modified BA, (n, %) | 28 (51.9%) | 97 (70.3%) | 0.016 |
Preoperative serum albumin level, median (range), (g/dl) | 4.0 (1.0–5.2) | 4.0 (2.1–4.9) | 0.607 |
Preoperative total lymphocyte count, median (range), (/μl) | 1504 (875–3168) | 1460 (550–5382) | 0.338 |
Serum amylase level on POD 1, median (range), (IU/l) | 432 (136–3953) | 246 (12–2324) | <  0.001 |
Serum amylase level on POD 3, median (range), (IU/l) | 102 (28–665) | 64 (8–1406) | 0.001 |
Drain amylase level on POD 1, median (range), (IU/l) | 8652 (66–985,053) | 957.5 (12–65,568) | <  0.001 |
Drain amylase level on POD 3, median (range), (IU/l) | 1313 (450–42,370) | 187.5 (4–23,814) | <  0.001 |
Serum CRP level on POD 1 (range), (mg/dl) | 7.83 (4.33–17.76) | 7.32 (1.04–20.46) | 0.160 |
Serum CRP level on POD 3 (range), (mg/dl) | 21.68 (4.85–37.52) | 11.46 (0.88–37.56) | <  0.001 |
Preoperative PNI, median (range) | 48.4 (36.6–59.8) | 47.7 (24.6–72.9) | 0.439 |
PNI on POD 1, median (range) | 31.3 (22.7–41.6) | 31.4 (19.4–46.5) | 0.795 |
PNI on POD 3, median (range) | 29.5 (23.5–40.3) | 32.4 (22.2–49.1) | 0.007 |
PNIP1-Pre ratio, median (range) | 65.3 (49–92) | 67.6 (41–108) | 0.577 |
PNIP3-Pre ratio, median (range) | 62.4 (46–82) | 68.3 (44–111) | 0.003 |
PNIP3-P1 ratio, median (range) | 94.6 (65–122) | 101.7 (75–140) | <  0.001 |